American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in Hyderabad. This strategic move aims to bolster its global manufacturing and supply capabilities, leveraging India’s skilled workforce to develop and produce medicines for critical ailments.